Yun‐Li Zhao

2.6k total citations
105 papers, 2.1k citations indexed

About

Yun‐Li Zhao is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Yun‐Li Zhao has authored 105 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 45 papers in Pharmacology and 25 papers in Pharmacology. Recurrent topics in Yun‐Li Zhao's work include Alkaloids: synthesis and pharmacology (38 papers), Natural product bioactivities and synthesis (19 papers) and Berberine and alkaloids research (16 papers). Yun‐Li Zhao is often cited by papers focused on Alkaloids: synthesis and pharmacology (38 papers), Natural product bioactivities and synthesis (19 papers) and Berberine and alkaloids research (16 papers). Yun‐Li Zhao collaborates with scholars based in China, Pakistan and Cameroon. Yun‐Li Zhao's co-authors include Xiao‐Dong Luo, Yaping Liu, Jian‐Hua Shang, Tao Feng, Xing‐Wei Yang, Xiang‐Hai Cai, Xu‐Jie Qin, Lu Liu, Bei Wang and Peifen Zhu and has published in prestigious journals such as Chemical Communications, Journal of Agricultural and Food Chemistry and Scientific Reports.

In The Last Decade

Yun‐Li Zhao

102 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yun‐Li Zhao China 28 816 793 484 411 334 105 2.1k
Juriyati Jalil Malaysia 25 286 0.4× 624 0.8× 258 0.5× 471 1.1× 159 0.5× 76 1.9k
Arunporn Itharat Thailand 25 658 0.8× 935 1.2× 249 0.5× 745 1.8× 142 0.4× 192 2.5k
Phương Thiện Thương South Korea 30 285 0.3× 1.2k 1.6× 276 0.6× 644 1.6× 234 0.7× 80 2.1k
Ren Xiang Tan China 21 217 0.3× 689 0.9× 364 0.8× 377 0.9× 303 0.9× 51 1.5k
Jinlan Ruan China 22 227 0.3× 749 0.9× 179 0.4× 463 1.1× 195 0.6× 100 1.9k
Lie-Chwen Lin Taiwan 30 670 0.8× 1.1k 1.4× 560 1.2× 468 1.1× 369 1.1× 70 2.9k
Jiro Ogura Japan 22 150 0.2× 748 0.9× 254 0.5× 256 0.6× 99 0.3× 73 2.1k
Paul AM van Leeuwen Netherlands 7 218 0.3× 823 1.0× 267 0.6× 652 1.6× 263 0.8× 7 2.7k
Long Xie China 25 365 0.4× 866 1.1× 484 1.0× 405 1.0× 166 0.5× 58 2.1k
Md. Areeful Haque Malaysia 26 596 0.7× 651 0.8× 193 0.4× 510 1.2× 132 0.4× 58 2.1k

Countries citing papers authored by Yun‐Li Zhao

Since Specialization
Citations

This map shows the geographic impact of Yun‐Li Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yun‐Li Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yun‐Li Zhao more than expected).

Fields of papers citing papers by Yun‐Li Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yun‐Li Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yun‐Li Zhao. The network helps show where Yun‐Li Zhao may publish in the future.

Co-authorship network of co-authors of Yun‐Li Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Yun‐Li Zhao. A scholar is included among the top collaborators of Yun‐Li Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yun‐Li Zhao. Yun‐Li Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jingya, Zhenyu Ji, Di Wu, et al.. (2025). MYBL2 promotes cell proliferation and inhibits cell apoptosis via PI3K/AKT and BCL2/BAX/Cleaved-caspase-3 signaling pathway in gastric cancer cells. Scientific Reports. 15(1). 9148–9148. 2 indexed citations
2.
Zhu, Yanyan, et al.. (2024). Oleanolic acid derivatives against drug-resistant bacteria and fungi by multi-targets to avoid drug resistance. European Journal of Medicinal Chemistry. 280. 116940–116940. 3 indexed citations
3.
Zhu, Yanyan, et al.. (2024). Diterpenoids of Caryopteris trichosphaera W. W. Sm. inhibiting MRSA and VRE in vitro and in vivo. Journal of Ethnopharmacology. 337(Pt 1). 118805–118805. 3 indexed citations
4.
Shi, Nian, Zhao‐Jie Wang, Ling Jiang, et al.. (2024). New resorcylic acid derivatives of Lysimachia tengyuehensis against MRSA and VRE by interfering with bacterial metabolic imbalance. European Journal of Medicinal Chemistry. 277. 116714–116714. 6 indexed citations
5.
Yan, Xiaojun, et al.. (2024). Formononetin Derivative for Osteoporosis by Simultaneous Regulating Osteoblast and Osteoclast. Journal of Natural Products. 87(8). 2004–2013. 2 indexed citations
6.
Huang, H. Z., et al.. (2024). 6-Methoxyldihydrochelerythrine Chloride Inhibiting Intra and Extracellular Drug-Resistant Bacteria. ACS Infectious Diseases. 10(9). 3430–3439. 1 indexed citations
7.
Zhao, Yun‐Li, et al.. (2024). Liver injury protection of Artemisia stechmanniana besser through PI3K/AKT pathway. Journal of Ethnopharmacology. 334. 118590–118590. 5 indexed citations
8.
Zhao, Yun‐Li, et al.. (2024). Three New Ent-Kaurane Diterpenes with Antibacterial Activity from Sigesbeckia orientalis. Molecules. 29(19). 4631–4631. 1 indexed citations
10.
Zhao, Yun‐Li, et al.. (2023). Undescribed indole lactones from Alstonia scholaris protecting hepatic cell damage. Phytochemistry. 217. 113926–113926. 3 indexed citations
12.
Guo, Rui, et al.. (2023). Pharmacological investigation of indole alkaloids from Alstonia scholaris against chronic glomerulonephritis. Phytomedicine. 118. 154958–154958. 12 indexed citations
13.
Chen, Shanshan, Haoran Wang, Bo Wu, et al.. (2023). Natural Coumarin Isomers with Dramatically Different AIE Properties: Mechanism and Application. ACS Central Science. 9(5). 883–891. 45 indexed citations
14.
Wang, Mingyue, et al.. (2023). Anti-hyperuricemia effect of hesperetin is mediated by inhibiting the activity of xanthine oxidase and promoting excretion of uric acid. Frontiers in Pharmacology. 14. 1128699–1128699. 21 indexed citations
15.
Zhao, Yun‐Li, Weiguang Ma, Yifen Wang, et al.. (2020). Anti-Inflammatory Indole Alkaloids from the Stems of Kopsia officinalis. Chinese Journal of Organic Chemistry. 40(3). 679–679. 7 indexed citations
16.
Dai, Zhi, Hui Liu, Hui Liu, et al.. (2020). Structures/cytotoxicity/selectivity relationship of natural steroidal saponins against GSCs and primary mechanism of tribulosaponin A. European Journal of Medicinal Chemistry. 210. 113068–113068. 14 indexed citations
17.
Wang, Mingyue, et al.. (2020). Isoorientin exerts a urate-lowering effect through inhibition of xanthine oxidase and regulation of the TLR4-NLRP3 inflammasome signaling pathway. Journal of Natural Medicines. 75(1). 129–141. 28 indexed citations
18.
Zhao, Yun‐Li, Min Su, Jian‐Hua Shang, et al.. (2020). Acute and Sub-chronic Toxicity of Indole Alkaloids Extract from Leaves of Alstonia scholaris (L.) R. Br. in Beagle Dogs. Natural Products and Bioprospecting. 10(4). 209–220. 12 indexed citations
19.
Li, Rui, Zhongping Gou, Yun‐Li Zhao, et al.. (2019). Pharmacokinetics and safety evaluation in healthy Chinese volunteers of alkaloids from leaf of Alstonia scholaris: A multiple doses phase I clinical trial. Phytomedicine. 61. 152828–152828. 17 indexed citations
20.
Shang, Jian‐Hua, Xiang‐Hai Cai, Tao Feng, et al.. (2010). Pharmacological evaluation of Alstonia scholaris: Anti-inflammatory and analgesic effects. Journal of Ethnopharmacology. 129(2). 174–181. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026